Compound(s) secreted by Lactobacillus casei strain Shirota YIT9029 irreversibly and reversibly impair the swimming motility of Helicobacter pylori and Salmonella enterica serovar Typhimurium, respectively

Microbiology (United Kingdom)

Volumn 159, Issue PART 9, 2013, Pages 1956-1971

  Liévin Le Moal, Vanessa ^a,b   Fayol Messaoudi, Domitille ^a,b   Servin, Alain L ^a,b  

^a UNIVERSITÉ PARIS SUD   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLAGELLIN; LACTIC ACID; TRYPSIN;

ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL STRAIN; CELL MEMBRANE DEPOLARIZATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; HELICOBACTER PYLORI; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE CELL; LACTOBACILLUS CASEI; MOTILITY SWIMMING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM;

EID: 84883381097     PISSN: 13500872     EISSN: 14652080     Source Type: Journal    
DOI: 10.1099/mic.0.067678-0     Document Type: Article

References (75)

1. Alakomi, H. L., Skyttä, E., Saarela, M., Mattila-Sandholm, T., Latva-Kala, K. & Helander, I. M. (2000). Lactic acid permeabilizes gramnegative bacteria by disrupting the outer membrane. Appl Environ Microbiol 66, 2001-2005.
2. Aldridge, P. & Hughes, K. T. (2002). Regulation of flagellar assembly. Curr Opin Microbiol 5, 160-165.
3. Asahara, T., Shimizu, K., Takada, T., Kado, S., Yuki, N., Morotomi, M., Tanaka, R. & Nomoto, K. (2011). Protective effect of Lactobacillus casei strain Shirota against lethal infection with multi-drug resistant Salmonella enterica serovar Typhimurium DT104 in mice. J Appl Microbiol 110, 163-173.
4. Atassi, F. & Servin, A. L. (2010). Individual and co-operative roles of lactic acid and hydrogen peroxide in the killing activity of enteric strain Lactobacillus johnsonii NCC933 and vaginal strain Lactobacillus gasseri KS120.1 against enteric, uropathogenic and vaginosis-associated pathogens. FEMS Microbiol Lett 304, 29-38.
5. Avonts, L. & De Vuyst, L. (2001). Antimicrobial potential of probiotic lactic acid bacteria. Meded Rijksuniv Gent Fak Landbouwkd Toegep Biol Wet 66 (3b), 543-550.
6. Azevedo, N. F., Almeida, C., Cerqueira, L., Dias, S., Keevil, C. W. & Vieira, M. J. (2007). Coccoid form of Helicobacter pylori as a morphological manifestation of cell adaptation to the environment. Appl Environ Microbiol 73, 3423-3427.
7. Berry, V., Jennings, K. & Woodnutt, G. (1995). Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob Agents Chemother 39, 1859-1861.
8. Bland, M. V., Ismail, S., Heinemann, J. A. & Keenan, J. I. (2004). The action of bismuth against Helicobacter pylori mimics but is not caused by intracellular iron deprivation. Antimicrob Agents Chemother 48, 1983-1988.
9. Bron, P. A., van Baarlen, P. & Kleerebezem, M. (2012). Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nat Rev Microbiol 10, 66-78.
10. Can, F., Karahan, C., Dolapci, I., Demirbilek, M., Tekeli, A. & Arslan, H. (2008). Urease activity and urea gene sequencing of coccoid forms of H. pylori induced by different factors. Curr Microbiol 56, 150-155.
11. Cats, A., Kuipers, E. J., Bosschaert, M. A., Pot, R. G., Vandenbroucke-Grauls, C. M. & Kusters, J. G. (2003). Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 17, 429-435.
12. Chantret, I., Rodolosse, A., Barbat, A., Dussaulx, E., Brot-Laroche, E., Zweibaum, A. & Rousset, M. (1994). Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation. J Cell Sci 107, 213-225.
13. Chevance, F. F. & Hughes, K. T. (2008). Coordinating assembly of a bacterial macromolecular machine. Nat Rev Microbiol 6, 455-465.
14. Coconnier, M. H., Liévin, V., Bernet-Camard, M. F., Hudault, S. & Servin, A. L. (1997). Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41, 1046-1052.
15. Coconnier, M. H., Lievin, V., Hemery, E. & Servin, A. L. (1998). Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl Environ Microbiol 64, 4573-4580.
16. Coconnier, M. H., Liévin, V., Lorrot, M. & Servin, A. L. (2000). Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells. Appl Environ Microbiol 66, 1152-1157.
17. Coconnier-Polter, M. H., Liévin-Le Moal, V. & Servin, A. L. (2005). A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica serovar Typhimurium by triggering lethal bacterial membrane damage. Appl Environ Microbiol 71, 6115-6120.
18. Corthésy-Theulaz, I., Porta, N., Pringault, E., Racine, L., Bogdanova, A., Kraehenbuhl, J. P., Blum, A. L. & Michetti, P. (1996). Adhesion of Helicobacter pylori to polarized T84 human intestinal cell monolayers is pH dependent. Infect Immun 64, 3827-3832.
19. Cover, T. L. & Blaser, M. J. (2009). Helicobacter pylori in health and disease. Gastroenterology 136, 1863-1873.
20. de Waard, R., Garssen, J., Bokken, G. C. & Vos, J. G. (2002). Antagonistic activity of Lactobacillus casei strain Shirota against gastrointestinal Listeria monocytogenes infection in rats. Int J Food Microbiol 73, 93-100.
21. DeLoney, C. R. & Schiller, N. L. (1999). Competition of various blactam antibiotics for the major penicillin-binding proteins of Helicobacter pylori: antibacterial activity and effects on bacterial morphology. Antimicrob Agents Chemother 43, 2702-2709.
22. Dibb-Fuller, M. P., Allen-Vercoe, E., Thorns, C. J. & Woodward, M. J. (1999). Fimbriae-and flagella-mediated association with and invasion of cultured epithelial cells by Salmonella enteritidis. Microbiology 145, 1023-1031.
23. FAO/WHO (2001). Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, Cordoba, Argentina, 1-4 October 2001. http://www.who.int/foodsafety/publications/fs_management/ en/probiotics.pdf
24. Fayol-Messaoudi, D., Berger, C. N., Coconnier-Polter, M. H., Liévin-Le Moal, V. & Servin, A. L. (2005). pH-, lactic acid-, and non-lactic acid-dependent activities of probiotic lactobacilli against Salmonella enterica serovar Typhimurium. Appl Environ Microbiol 71, 6008-6013.
25. Fayol-Messaoudi, D., Coconnier-Polter, M. H., Moal, V. L., Atassi, F., Berger, C. N. & Servin, A. L. (2007). The Lactobacillus plantarum strain ACA-DC287 isolated from a Greek cheese demonstrates antagonistic activity in vitro and in vivo against Salmonella enterica serovar Typhimurium. J Appl Microbiol 103, 657-665.
26. Galán, J. E. (2001). Salmonella interactions with host cells: type III secretion at work. Annu Rev Cell Dev Biol 17, 53-86.
27. Grassl, G. A. & Finlay, B. B. (2008). Pathogenesis of enteric Salmonella infections. Curr Opin Gastroenterol 24, 22-26.
28. Harshey, R. M. (2003). Bacterial motility on a surface: many ways to a common goal. Annu Rev Microbiol 57, 249-273.
29. Hoiseth, S. K. & Stocker, B. A. (1981). Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291, 238-239.
30. Isobe, H., Nishiyama, A., Takano, T., Higuchi, W., Nakagawa, S., Taneike, I., Fukushima, Y. & Yamamoto, T. (2012). Reduction of overall Helicobacter pylori colonization levels in the stomach of Mongolian gerbil by Lactobacillus johnsonii La1 (LC1) and its in vitro activities against H. pylori motility and adherence. Biosci Biotechnol Biochem 76, 850-852.
31. Jones, B. D., Lee, C. A. & Falkow, S. (1992). Invasion by Salmonella typhimurium is affected by the direction of flagellar rotation. Infect Immun 60, 2475-2480.
32. Josenhans, C. & Suerbaum, S. (2002). The role of motility as a virulence factor in bacteria. Int J Med Microbiol 291, 605-614.
33. Karim, Q. N., Logan, R. P., Puels, J., Karnholz, A. & Worku, M. L. (1998). Measurement of motility of Helicobacter pylori, Campylobacter jejuni, and Escherichia coli by real time computer tracking using the Hobson BacTracker. J Clin Pathol 51, 623-628.
34. Kleerebezem, M., Hols, P., Bernard, E., Rolain, T., Zhou, M., Siezen, R. J. & Bron, P. A. (2010). The extracellular biology of the lactobacilli. FEMS Microbiol Rev 34, 199-230.
35. Lebeer, S., Vanderleyden, J. & De Keersmaecker, S. C. (2008). Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev 72, 728-764.
36. Lee, S. K., Stack, A., Katzowitsch, E., Aizawa, S. I., Suerbaum, S. & Josenhans, C. (2003). Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect 5, 1345-1356.
37. Lertsethtakarn, P., Ottemann, K. M. & Hendrixson, D. R. (2011). Motility and chemotaxis in Campylobacter and Helicobacter. Annu Rev Microbiol 65, 389-410.
38. Lesuffleur, T., Barbat, A., Dussaulx, E. & Zweibaum, A. (1990). Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res 50, 6334-6343.
39. Leying, H., Suerbaum, S., Geis, G. & Haas, R. (1992). Cloning and genetic characterization of a Helicobacter pylori flagellin gene. Mol Microbiol 6, 2863-2874.
40. Liévin-Le Moal, V., Servin, A. L. & Coconnier-Polter, M. H. (2005). The increase in mucin exocytosis and the upregulation of MUC genes encoding for membrane-bound mucins induced by the thiol-activated exotoxin listeriolysin O is a host cell defence response that inhibits the cell-entry of Listeria monocytogenes. Cell Microbiol 7, 1035-1048.
41. Liévin-Le Moal, V., Amsellem, R. & Servin, A. L. (2011). Impairment of swimming motility by antidiarrheic Lactobacillus acidophilus strain LB retards internalization of Salmonella enterica serovar Typhimurium within human enterocyte-like cells. Antimicrob Agents Chemother 55, 4810-4820.
42. Lockman, H. A. & Curtiss, R., III (1990). Salmonella typhimurium mutants lacking flagella or motility remain virulent in BALB/c mice. Infect Immun 58, 137-143.
43. Makras, L., Triantafyllou, V., Fayol-Messaoudi, D., Adriany, T., Zoumpopoulou, G., Tsakalidou, E., Servin, A. & De Vuyst, L. (2006). Kinetic analysis of the antibacterial activity of probiotic lactobacilli towards Salmonella enterica serovar Typhimurium reveals a role for lactic acid and other inhibitory compounds. Res Microbiol 157, 241-247.
44. Malago, J. J., Nemeth, E., Koninkx, J. F. J. G., Tooten, P. C. J., Fajdiga, S. & van Dijk, J. E. (2010). Microbial products from probiotic bacteria inhibit Salmonella enteritidis 857-induced IL-8 synthesis in Caco-2 cells. Folia Microbiol (Praha) 55, 401-408.
45. McCormick, B. A., Stocker, B. A., Laux, D. C. & Cohen, P. S. (1988). Roles of motility, chemotaxis, and penetration through and growth in intestinal mucus in the ability of an avirulent strain of Salmonella typhimurium to colonize the large intestine of streptomycin-treated mice. Infect Immun 56, 2209-2217.
46. Michetti, P., Porta, N., Mahan, M. J., Slauch, J. M., Mekalanos, J. J., Blum, A. L., Kraehenbuhl, J. P. & Neutra, M. R. (1994). Monoclonal immunoglobulin A prevents adherence and invasion of polarized epithelial cell monolayers by Salmonella typhimurium. Gastroenterology 107, 915-923.
47. Minamino, T., Imada, K. & Namba, K. (2008). Molecular motors of the bacterial flagella. Curr Opin Struct Biol 18, 693-701.
48. Mouery, K., Rader, B. A., Gaynor, E. C. & Guillemin, K. (2006). The stringent response is required for Helicobacter pylori survival of stationary phase, exposure to acid, and aerobic shock. J Bacteriol 188, 5494-5500.
49. O'Regan, E., Quinn, T., Frye, J. G., Pagès, J. M., Porwollik, S., Fedorka-Cray, P. J., McClelland, M. & Fanning, S. (2010). Fitness costs and stability of a high-level ciprofloxacin resistance phenotype in Salmonella enterica serotype Enteritidis: reduced infectivity associated with decreased expression of Salmonella pathogenicity island 1 genes. Antimicrob Agents Chemother 54, 367-374.
50. Patrick, J. E. & Kearns, D. B. (2012). Swarming motility and the control of master regulators of flagellar biosynthesis. Mol Microbiol 83, 14-23.
51. Pontier-Bres, R., Prodon, F., Munro, P., Rampal, P., Lemichez, E., Peyron, J. F. & Czerucka, D. (2012). Modification of Salmonella Typhimurium motility by the probiotic yeast strain Saccharomyces boulardii. PLoS ONE 7, e33796.
52. Prasad, K., Caplan, S. R. & Eisenbach, M. (1998). Fumarate modulates bacterial flagellar rotation by lowering the free energy difference between the clockwise and counterclockwise states of the motor. J Mol Biol 280, 821-828.
53. Pridmore, R. D., Pittet, A. C., Praplan, F. & Cavadini, C. (2008). Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol Lett 283, 210-215.
54. Sahagún-Flores, J. E., López-Peña, L. S., de la Cruz-Ramírez Jaimes, J., García-Bravo, M. S., Peregrina-Gómez, R. & de Alba-García, J. E. (2007). [Eradication of Helicobacter pylori: triple treatment scheme plus Lactobacillus vs. triple treatment alone]. Cir Cir 75, 333-336 (in Spanish).
55. Saito, N., Konishi, K., Kato, M., Takeda, H., Asaka, M. & Ooi, H. K. (2008). Coccoid formation as a mechanism of species-preservation in Helicobacter pylori: an ultrastructural study. Hokkaido Igaku Zasshi 83, 291-295.
56. Salama, N. R., Hartung, M. L. & Müller, A. (2013). Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori. Nat Rev Microbiol 11, 385-399.
57. Sato, F., Saito, N., Konishi, K., Shoji, E., Kato, M., Takeda, H., Sugiyama, T. & Asaka, M. (2003). Ultrastructural observation of Helicobacter pylori in glucose-supplemented culture media. J Med Microbiol 52, 675-679.
58. Schreiber, S., Stüben, M., Josenhans, C., Scheid, P. & Suerbaum, S. (1999). In vivo distribution of Helicobacter felis in the gastric mucus of the mouse: experimental method and results. Infect Immun 67, 5151-5156.
59. Servin, A. L. (2004). Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 28, 405-440.
60. Sgouras, D., Maragkoudakis, P., Petraki, K., Martinez-Gonzalez, B., Eriotou, E., Michopoulos, S., Kalantzopoulos, G., Tsakalidou, E. & Mentis, A. (2004). In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl EnvironMicrobiol 70, 518-526.
61. Sgouras, D. N., Panayotopoulou, E. G., Martinez-Gonzalez, B., Petraki, K., Michopoulos, S. & Mentis, A. (2005). Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice. Clin Diagn Lab Immunol 12, 1378-1386.
62. She, F. F., Su, D. H., Lin, J. Y. & Zhou, L. Y. (2001). Virulence and potential pathogenicity of coccoid Helicobacter pylori induced by antibiotics. World J Gastroenterol 7, 254-258.
63. Shen, S. & Fang, F. C. (2012). Integrated stress responses in Salmonella. Int J Food Microbiol 152, 75-81.
64. Sojka, M., Sayers, A. R. & Woodward, M. J. (2001). Analysis of expression of flagella by Salmonella enterica serotype Typhimurium by monoclonal antibodies recognising both phase specific and common epitopes. Vet Microbiol 78, 61-77.
65. Sörberg, M., Hanberger, H., Nilsson, M., Björkman, A. & Nilsson, L. E. (1998). Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother 42, 1222-1228.
66. Spengler, G., Molnar, A., Klausz, G., Mandi, Y., Kawase, M., Motohashi, N. & Molnar, J. (2004). Inhibitory action of a new proton pump inhibitor, trifluoromethyl ketone derivative, against the motility of clarithromycin-susceptible and-resistant Helicobacter pylori. Int J Antimicrob Agents 23, 631-633.
67. Stecher, B., Hapfelmeier, S., Müller, C., Kremer, M., Stallmach, T. & Hardt, W. D. (2004). Flagella and chemotaxis are required for efficient induction of Salmonella enterica serovar Typhimurium colitis in streptomycin-pretreated mice. Infect Immun 72, 4138-4150.
68. Sycuro, L. K., Wyckoff, T. J., Biboy, J., Born, P., Pincus, Z., Vollmer, W. & Salama, N. R. (2012). Multiple peptidoglycan modification networks modulate Helicobacter pylori's cell shape, motility, and colonization potential. PLoS Pathog 8, e1002603.
69. Tsutsui, N., Taneike, I., Ohara, T., Goshi, S., Kojio, S., Iwakura, N., Matsumaru, H., Wakisaka-Saito, N., Zhang, H. M. & Yamamoto, T. (2000). A novel action of the proton pump inhibitor rabeprazole and its thioether derivative against the motility of Helicobacter pylori. Antimicrob Agents Chemother 44, 3069-3073.
70. Turner, L., Ryu, W. S. & Berg, H. C. (2000). Real-time imaging of fluorescent flagellar filaments. J Bacteriol 182, 2793-2801.
71. van Asten, F. J., Hendriks, H. G., Koninkx, J. F. & van Dijk, J. E. (2004). Flagella-mediated bacterial motility accelerates but is not required for Salmonella serotype Enteritidis invasion of differentiated Caco-2 cells. Int J Med Microbiol 294, 395-399.
72. Wang, J., Wang, W. H., Li, J. & Liu, F. X. (2010). Celecoxib inhibits Helicobacter pylori colonization-related factors. World J Gastroenterol 16, 846-853.
73. Winter, S. E., Thiennimitr, P., Nuccio, S. P., Haneda, T., Winter, M. G., Wilson, R. P., Russell, J. M., Henry, T., Tran, Q. T. & other authors (2009). Contribution of flagellin pattern recognition to intestinal inflammation during Salmonella enterica serotype Typhimurium infection. Infect Immun 77, 1904-1916.
74. Worku, M. L., Sidebotham, R. L. & Karim, Q. N. (1999a). Effects of ranitidine bismuth citrate on Helicobacter pylori motility, morphology and survival. Aliment Pharmacol Ther 13, 753-760.
75. Worku, M. L., Sidebotham, R. L., Walker, M. M., Keshavarz, T. & Karim, Q. N. (1999b). The relationship between Helicobacter pylori motility, morphology and phase of growth: implications for gastric colonization and pathology. Microbiology 145, 2803-2811.